We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Type 1 Diabetes Risk Reflected in Gut Microbiome

By LabMedica International staff writers
Posted on 06 Sep 2019
Type 1 diabetes mellitus (T1D) is an autoimmune disorder characterized by the destruction of insulin-producing ß-cells in the pancreas, resulting in a life-long dependence on exogenous insulin. More...
T1D is an autoimmune condition that can develop at any age.

According to recent estimates, there are 1.3 million adults in the USA living with diabetes. Although the causes of type 1 diabetes are not yet known, there are many risk factors for this metabolic condition. Genetic risk factors for T1D have been identified in over 50 diverse genetic loci, but the greatest genetic determinant of T1D remains the human leukocyte antigen (HLA) region.

A team of scientists including those from Linköping University (Linköping, Sweden) examined data available from the All Babies in Southeast Sweden (ABIS) study. They conducted the ABIS study with the aim of understanding why children develop conditions that primarily involve the immune system. The ABIS study contains data from questionnaires and biological samples on over 17,000 children born in 1997–1999. As part of the study, scientists collected biological samples "at birth, 1 year, 2–3 years, and 5–6 years of age." The samples included "blood, urine, stool, and hair."

To enable the comparison of different levels of HLA risk for developing T1D autoimmunity, subjects with available HLA genotype data were placed into one of four categories of risk based on their HLA genotype. DNA from each sample was extracted from ~200 mg of stool, using the E.Z.N.A Stool Extraction Kit. DNA used for subsequent polymerase chain reaction (PCR) was quantified and assessed for purity using a NanoDrop spectrophotometer. Amplicons from each sample were pooled and sequenced on the MiSeq platform.

The scientists reported that both the core microbiome and beta diversity differ with HLA risk group and genotype. In addition, protective HLA haplotypes are associated with bacterial genera Intestinibacter and Romboutsia. They found that children with a high genetic risk had a different composition in their gut microbiota and different gut microbiomes than children with a low risk. The authors concluded that the information gained from this type of cohort furthers our understanding of how HLA genetic risk drives changes in the gut microbiome and how genetics may be “setting the stage” for environmental triggers that ultimately lead to T1D autoimmunity. The study was published on August 9, 2019, in the journal Nature Communications.

Related Links:
Linköping University


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.